{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:20:42Z","timestamp":1769559642817,"version":"3.49.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.597813","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T17:35:56Z","timestamp":1605634556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["High Response Rate and Prolonged Survival of Unresectable Biliary Tract Cancer Treated With a New Combination Therapy Consisting of Intraarterial Chemotherapy Plus Radiotherapy"],"prefix":"10.3389","volume":"10","author":[{"given":"Takuma","family":"Goto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpei","family":"Sasajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nubuyuki","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugo","family":"Fujibayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihiro","family":"Fujiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn533","article-title":"Epidemiology of biliary tract cancers: an update","volume":"20","author":"Randi","year":"2009","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyl158","article-title":"International comparisons of cumulative risk of gallbladder cancer and other biliary tract cancer, from Cancer Incidence in Five Continents Vol. VIII","volume":"37","author":"Matsuda","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"B3","article-title":"Gallbladder and biliary tract carcinoma: a comprehensive update, part 2","volume":"18","author":"Daines","year":"2004","journal-title":"Oncology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301748","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update","volume":"61","author":"Khan","year":"2012","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jso.24093","article-title":"Multimodality treatment of intrahepatic cholangiocarcinoma: a review","volume":"113","author":"Simo","year":"2016","journal-title":"J Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00534-008-0015-0","article-title":"Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan","volume":"16","author":"Miyakawa","year":"2009","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine Alone or in Combination With Cisplatin in Patients With Biliary Tract Cancer: A Comparative Multicentre Study in Japan","volume":"103","author":"Okusaka","year":"2010","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1069-7","article-title":"Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall\u00a0bladder cancer: a Korean Cancer Study Group phase II trial","volume":"65","author":"Jang","year":"2010","journal-title":"Cancer\u00a0Chemother Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13104-015-1778-4","article-title":"A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract","volume":"9","author":"Graham","year":"2016","journal-title":"BMC Res Notes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1115-5","article-title":"Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer","volume":"65","author":"Sasaki","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1443-5","article-title":"A multi-institution phase II study of gemcitabine\/S-1 combination chemotherapy for patients with advanced biliary tract cancer","volume":"67","author":"Kanai","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12218","article-title":"Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805)","volume":"104","author":"Morizane","year":"2013","journal-title":"Cancer Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy082","article-title":"New developments in systemic therapy for advanced biliary tract cancer","volume":"48","author":"Morizane","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058113","article-title":"Etoposide (E) + epirubicin (E) + cisplatin (P) combination chemotherapy (EEP) in advanced gastric cancer: negative impact on clinical outcome. Spanish Cooperative Group for GI Tumor Therapy (T.T.D.)","volume":"10","author":"Rubio","year":"1992","journal-title":"Ann Oncol"},{"key":"B16","article-title":"Radiation combination intraarterial chemotherapy for advanced gallbladder cancer","volume":"12","author":"Hokotate","year":"2009","journal-title":"Tan Sui"},{"key":"B17","first-page":"795","article-title":"The study of combination therapy for arterial infusion chemotherapy and radiation therapy in unresectable gallbladder cancer","volume":"27","author":"Goto","year":"2013","journal-title":"JIBA"},{"key":"B18","article-title":"Clinical evaluation of hepatic arterial infusion of low dose-CDDP and 5-FU with hyperthermotherapy: a preliminary study for liver metastases from esophageal and gastric cancer","volume":"28","author":"Iwahashi","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"B19","article-title":"Pharmacokinetics in Arterial Infusion Chemotherapy","volume":"20","author":"Arai","year":"1993","journal-title":"Gan Kagaku Ryoho"},{"key":"B20","article-title":"Current status of biliary and pancreatic cancer chemotherapy in Japan","volume":"21","author":"Fukuda","year":"2000","journal-title":"Tan Sui"},{"key":"B21","article-title":"Capecitabine plus hepatic intra- arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study","volume":"27","author":"Mambrini","year":"2007","journal-title":"Anticancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3127-y","article-title":"Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis intra-arterial therapy (IAT) for ICC","volume":"20","author":"Hyder","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S166246","article-title":"Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection","volume":"11","author":"Chen","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-010-0783-1","article-title":"BeneWt of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases","volume":"136","author":"Jiang","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/1471-2407-13-568","article-title":"Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma","volume":"13","author":"Moureau-Zabotto","year":"2013","journal-title":"BMC Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.03.018","article-title":"Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma","volume":"72","author":"Shinohara","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable Intrahepatic Cholangiocarcinoma: a retrospective dose response analysis","volume":"34","author":"Tao","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B28","article-title":"Indication and significance of extended surgery for gallbladder cancer","volume":"95","author":"Shimizu","year":"2006","journal-title":"tando"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1477-2574.2011.00431.x","article-title":"Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study","volume":"14","author":"Fukutomi","year":"2012","journal-title":"HPB (Oxford)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.597813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T17:36:01Z","timestamp":1605634561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.597813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":29,"alternative-id":["10.3389\/fonc.2020.597813"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.597813","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"article-number":"597813"}}